Evidence map›Paper›PMID 36680053›Full record

ArticleViruses2022

Epidemiological Patterns of Seasonal Respiratory Viruses during the COVID-19 Pandemic in Madagascar, March 2020-May 2022.

Norosoa Harline Razanajatovo, Tsiry Hasina Randriambolamanantsoa, Joelinotahiana Hasina Rabarison, Laurence Randrianasolo, Miamina Fidy Ankasitrahana, Arvé Ratsimbazafy, Antso Hasina Raherinandrasana, Helisoa Razafimanjato, Vololoniaina Raharinosy, Soa Fy Andriamandimby and 3 more

Abstract read
In one paragraph

Article in Viruses, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Norosoa Harline RazanajatovoNational Influenza Center, Virology Unit, Institut Pasteur of Madagascar, Antananarivo 101, Madagascar.
Tsiry Hasina RandriambolamanantsoaNational Influenza Center, Virology Unit, Institut Pasteur of Madagascar, Antananarivo 101, Madagascar.
Joelinotahiana Hasina RabarisonNational Influenza Center, Virology Unit, Institut Pasteur of Madagascar, Antananarivo 101, Madagascar.
Laurence RandrianasoloEpidemiology and Clinical Research Unit, Institut Pasteur of Madagascar, Antananarivo 101, Madagascar.
Miamina Fidy AnkasitrahanaDirection de la Veille Sanitaire, de la Surveillance Epidémiologique et Ripostes, Ministry of Public Health, Antananarivo 101, Madagascar.
Arvé RatsimbazafyNational Influenza Center, Virology Unit, Institut Pasteur of Madagascar, Antananarivo 101, Madagascar.
Antso Hasina RaherinandrasanaDirection de la Veille Sanitaire, de la Surveillance Epidémiologique et Ripostes, Ministry of Public Health, Antananarivo 101, Madagascar.
Helisoa RazafimanjatoNational Influenza Center, Virology Unit, Institut Pasteur of Madagascar, Antananarivo 101, Madagascar.
Vololoniaina RaharinosyNational Influenza Center, Virology Unit, Institut Pasteur of Madagascar, Antananarivo 101, Madagascar.
Soa Fy AndriamandimbyNational Influenza Center, Virology Unit, Institut Pasteur of Madagascar, Antananarivo 101, Madagascar.
Jean-Michel HeraudVirology Department, Institut Pasteur de Dakar, Dakar 12900, Senegal.ORCID 0000-0003-1107-0859
Philippe DussartNational Influenza Center, Virology Unit, Institut Pasteur of Madagascar, Antananarivo 101, Madagascar.ORCID 0000-0002-1931-3037
Vincent LacosteNational Influenza Center, Virology Unit, Institut Pasteur of Madagascar, Antananarivo 101, Madagascar.

Funding

NCIRD CDC HHS U51 IP000812
6 · The paper itself

Abstract

Three epidemic waves of coronavirus disease-19 (COVID-19) occurred in Madagascar from March 2020 to May 2022, with a positivity rate of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) of 21% to 33%. Our study aimed to identify the impact of COVID-19 on the epidemiology of seasonal respiratory viruses (RVs) in Madagascar. We used two different specimen sources (SpS). First, 2987 nasopharyngeal (NP) specimens were randomly selected from symptomatic patients between March 2020 and May 2022 who tested negative for SARS-CoV-2 and were tested for 14 RVs by multiplex real-time PCR. Second, 6297 NP specimens were collected between March 2020 and May 2022 from patients visiting our sentinel sites of the influenza sentinel network. The samples were tested for influenza, respiratory syncytial virus (RSV), and SARS-CoV-2. From SpS-1, 19% (569/2987) of samples tested positive for at least one RV. Rhinovirus (6.3%, 187/2987) was the most frequently detected virus during the first two waves, whereas influenza predominated during the third. From SpS-2, influenza, SARS-CoV-2, and RSV accounted for 5.4%, 24.5%, and 39.4% of the detected viruses, respectively. During the study period, we observed three different RV circulation profiles. Certain viruses circulated sporadically, with increased activity in between waves of SARS-CoV-2. Other viruses continued to circulate regardless of the COVID-19 situation. Certain viruses were severely disrupted by the spread of SARS-CoV-2. Our findings underline the importance and necessity of maintaining an integrated disease surveillance system for the surveillance and monitoring of RVs of public health interest.

Indexed as

COVID-19Influenza, HumanRespiratory Syncytial Virus, HumanRespiratory Tract InfectionsVirusesHumansMadagascarPandemicsSARS-CoV-2SeasonsAfricadetectionepidemicsepidemiologyetiologyMadagascarSARS-CoV-2viruses

Identifiers

PMID36680053
PMCPMC9864023

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.